top of page

HSCT Research Hub

BA7A34C6-C12B-4A28-8C3E-D3C098A28B19_edi

Everything you need to know to research HSCT for MS. 

What is MS?

AIMS’ Multiple Sclerosis Overview, Diagnosis and MS Treatment Options

What is Autoimmune Disease?

What Exactly is an Autoimmune Disease/Disorder?
Find Out with the AIMS Overview of Diseases, Causes, Symptoms

What Is HSCT?

A comprehensive guide to HSCT.

HSCT FAQ

AIMS spoke with people from all over the world who have received HSCT.

Myths

HSCT Case Studies (Patient Testimonials)

UK HSCT Criteria

Patient Eligibility Criteria Adopted by the London MS-AHSCT Collaborative Group

Peer Reviewed Studies

Sources of the latest research and peer reviewed publications about HSCT

We Asked The Experts

Just before Covid struck, AIMS was lucky enough to interview 3 of the most respected and experienced HSCT practitioners on the planet - Dr Guillermo J. Ruiz-Arguelles, from Clinica Ruiz, Puebla, Mexico, Dr Denis Fedorenko, from Pirogov Hospital, Moscow, and Dr Majid Kazmi, from King’s College Hospital and London Bridge.

Patient Testimonials

AIMS spoke with people from all over the world who have received HSCT.

StarMS Trial

Autologous Stem Cell Transplantation versus Alemtuzumab, Ocrelizumab, Ofatumumab or Cladribine in Relapsing Remitting Multiple Sclerosis

HSCT Coming Of Age

Review from Dr Majid Kazmi
Consultant Haematologist

Clinical Trials

Find out about current trials

bottom of page